Tempest Therapeutics (TPST) Institutional Ownership $1.81 -0.05 (-2.69%) Closing price 04:00 PM EasternExtended Trading$1.80 -0.02 (-0.83%) As of 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tempest Therapeutics (NASDAQ:TPST)CurrentInstitutional OwnershipPercentage22.52%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$832.75KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$24.75M Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TPST Institutional Buying and Selling by Quarter Tempest Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2026 Sabby Management LLC178,592$513K0.7%N/A3.623% 2/12/2026 DRW Securities LLC10,447$30K0.0%-44.5%0.212% 2/12/2026 Dimensional Fund Advisors LP11,444$33K0.0%N/A0.232% 11/7/2025Vanguard Group Inc.162,560$1.67M0.0%+20.8%3.661% 8/11/2025 Versant Venture Management LLC269,772$1.83M2.2%-92.3%7.331% 8/8/2025 Geode Capital Management LLC34,736$236K0.0%-92.0%0.944% 2/17/2025Millennium Management LLC189,506$158K0.0%N/A0.434% 2/14/2025Jane Street Group LLC493,094$411K0.0%N/A1.130% 2/14/2025Northern Trust Corp67,815$57K0.0%+233.2%0.155% 2/13/2025XTX Topco Ltd160,807$134K0.0%+570.3%0.368% 2/12/2025Geode Capital Management LLC354,276$296K0.0%+61.0%0.812% 2/12/2025Versant Venture Management LLC3,507,055$2.93M3.4%N/A8.036% 2/11/2025Virtu Financial LLC43,105$36K0.0%N/A0.099% 11/16/2024Geode Capital Management LLC220,067$308K0.0%+42.7%0.873% 11/15/2024XTX Topco Ltd23,989$34K0.0%N/A0.095% 11/5/2024Empower Advisory Group LLC35,000$49K0.0%N/A0.139% 10/29/2024Fullcircle Wealth LLC62,000$87K0.0%N/A0.279% 8/9/2024Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113% 5/20/2024Virtu Financial LLC28,574$112K0.0%+69.2%0.129% 2/15/2024MayTech Global Investments LLC10,000$44K0.0%N/A0.052% 8/14/2023Rock Springs Capital Management LP536,214$681K0.0%-34.9%4.026% 8/11/2023Sectoral Asset Management Inc.219,394$279K0.0%N/A1.893% 2/14/2022Maven Securities LTD77,377$409K0.0%-39.0%1.120% TPST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TPST shares? During the previous two years, 13 institutional investors and hedge funds held shares of Tempest Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($1.83M), Vanguard Group Inc. ($1.67M), Sabby Management LLC ($513K), Jane Street Group LLC ($411K), Geode Capital Management LLC ($236K), Millennium Management LLC ($158K), and XTX Topco Ltd ($134K).Learn more on Tempest Therapeutics' institutional investors. What percentage of Tempest Therapeutics' stock is owned by institutional investors? 22.52% of Tempest Therapeutics' stock is owned by institutional investors. Learn more on TPST's institutional investor holdings. Which institutional investors have been buying Tempest Therapeutics' stock? Of the 12 institutional investors that purchased Tempest Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($3.51M), Jane Street Group LLC ($493.09K), Geode Capital Management LLC ($200.04K), Millennium Management LLC ($189.51K), Sabby Management LLC ($178.59K), XTX Topco Ltd ($160.81K), and Fullcircle Wealth LLC ($62K). How much institutional buying is happening at Tempest Therapeutics? Institutional investors have bought a total of 217,988 shares in the last 24 months. This purchase volume represents approximately $832.75K in transactions. Which of Tempest Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Tempest Therapeutics stock in the last 24 months: Versant Venture Management LLC ($3.24M), Geode Capital Management LLC ($398.61K), and DRW Securities LLC ($8.38K). How much institutional selling is happening at Tempest Therapeutics? Institutional investors have sold a total of 3,644,274 shares in the last 24 months. This volume of shares sold represents approximately $24.75M in transactions. Related Companies THAR Major Shareholders CUE Major Shareholders TTRX Major Shareholders CRDF Major Shareholders BMEA Major Shareholders CGTX Major Shareholders ALDX Major Shareholders ONCY Major Shareholders NRXP Major Shareholders ANIX Major Shareholders This page (NASDAQ:TPST) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
